Related Experiment Video
Updated: Jun 26, 2026
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
Published on: January 29, 2019
Process in the mechanisms of endostatin combined with radiotherapy
Hong-Qing Zhuang1, Zhi-Yong Yuan
1Department of Radiotherapy, Tianjin Cancer Institute and Hospital, Key Laboratory of Cancer Prevention and Therapy, Tianjin, PR China.
Abstract:
Endostatin has been demonstrated to represent a promising novel medicine to treat malignant tumors, and it may be more effective when combined with conventional treatment. Meanwhile, a promising area of research in radiation oncology is the integration of molecular targeting agents to improve the effectiveness of radiotherapy (RT) in the control of primary tumor. Antiangiogenic agents are one such class of targeted therapies and have shown promise in both laboratory and clinical experiments. Endostatin in combination with RT has feasibility; but it also has lots of problems. Further understanding of the mechanisms is needed.
Insights
Endostatin shows promise as a cancer treatment, especially when combined with radiotherapy (RT). However, further research is needed to understand and overcome challenges associated with this combination therapy.
Area of Science:
- Oncology
- Radiation Oncology
- Molecular Biology
Background:
- Endostatin is a potential anti-cancer drug targeting tumor angiogenesis.
- Radiotherapy (RT) is a conventional cancer treatment.
- Combining targeted therapies with RT is an active area of research.
Purpose of the Study:
- To evaluate the potential of endostatin in combination with radiotherapy for cancer treatment.
- To explore the feasibility and challenges of integrating endostatin with RT.
Main Methods:
- Review of existing preclinical and clinical data on endostatin and RT.
- Analysis of the mechanisms of action for endostatin and its interaction with RT.
Main Results:
- Endostatin shows promise as an anti-cancer agent.
- Combination of endostatin with RT is feasible but presents challenges.
- Further understanding of the underlying mechanisms is required.
Conclusions:
- Endostatin holds potential for cancer therapy, particularly in conjunction with RT.
- Significant challenges remain in optimizing the combination of endostatin and RT.
- More research into the mechanisms is crucial for clinical application.
More Related Videos
07:20Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
Published on: January 14, 2011
10:28Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT
Published on: January 22, 2018